About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Asthma Clinical Trials in Chicago | 145 Studies

Clinical Trials AsthmaChicago

Asthma Clinical Trials in Chicago

Find 145 clinical trials for asthma near Chicago, Illinois. Connect with research centers in your area.

All Asthma trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 145 trials

CompletedAlendronate to Prevent Loss of Bronchoprotection in AsthmaBeta-2-agonists are effective in reducing airway narrowing in asthma and protecting against stimuli that produce bronchoconstriction.NCT02230332·Tucson, Arizona and 9 others CompletedA Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Low-Dose ICS Therapy.This study is designed to determine if the investigational drug is effective and safe in individuals with asthma.NCT00603278·Phoenix, Arizona and 154 others

Asthma Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedThe Community United to Challenge AsthmaThis study compares an asthma self-management intervention, delivered to the family and tailored to their needs and cultural beliefs, to standard asthma education in high-risk…NCT01061424·Chicago, Illinois

Enrolling by invitationEfficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)This is a parallel, Phase 3, 2-arm study to evaluate the efficacy and long-term safety of dupilumab treatment in children 2 to \<6 years of age with uncontrolled asthma and/or…NCT06191315·Phoenix, Arizona and 73 others

CompletedRandomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic PatientsA randomized multiple-dose, placebo-controlled, parallel group design consisting of a 2-week run-in period followed by a 6-week treatment period of the placebo, Test product…NCT03015259·Birmingham, Alabama and 94 others

CompletedStudy of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood EosinophilsThe primary objective of this study is to determine the effect of reslizumab (110 mg) administered subcutaneously every 4 weeks on clinical asthma exacerbations in adults and…NCT02452190·Birmingham, Alabama and 225 others

CompletedAsthma Phenotypes in the Inner CityThis is an epidemiologic, multi-center, cross-sectional study to define the phenotypic characteristics of Difficult-to-Treat asthma, among children between the ages of 6 to 17…NCT01383941·Denver, Colorado and 8 others

TerminatedEffectiveness and Safety Study for JNJ-18054478 in Asthma Patients.The purpose of this study is to assess the effectiveness of JNJ-18054478 measured by the percent change from baseline in Forced Expiratory Volume in one Second (FEV1) after 12…NCT00530166·Scottsdale, Arizona and 35 others

CompletedA Study in Participants With Asthma Initiating Treatment With Omalizumab (Xolair)This multicenter, prospective study will evaluate the baseline participant characteristics (including biomarkers) associated with a variety of individual and composite clinical…NCT01922037·Birmingham, Alabama and 144 others

CompletedCoordinated Healthcare Interventions for Childhood Asthma Gaps in OutcomesChicago is an epicenter for asthma health disparities in the U.S., with African-American children 5-11 yrs bearing a disproportionate share of the burden.NCT02319967·Chicago, Illinois and 5 others

CompletedAn Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood EosinophilsThe primary objective of the study is to determine the ability of reslizumab administered by subcutaneous injection to produce a corticosteroid-sparing effect in patients with…NCT02501629·Bakersfield, California and 126 others

CompletedA Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.This study is designed to determine if the investigational drug is effective and safe in individuals with asthma.NCT00603746·Phoenix, Arizona and 153 others

CompletedEfficacy and Safety of Levalbuterol Versus Racemic Albuterol in AsthmaTo investigate the Efficacy and Safety of Levalbuterol versus Racemic Albuterol in the Treatment of Acute Asthma.NCT00667407·Hoover, Alabama and 27 others

RecruitingPost-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School AgeDespite improved survival of extremely premature infants in recent decades, neonatal intensive care unit (NICU) graduates are diagnosed with asthma, sleep disordered breathing…NCT05336890·Chicago, Illinois

CompletedGB001 in Adult Subjects With Moderate to Severe AsthmaA randomized, double-blind, placebo-controlled, dose-ranging, multi-center study to evaluate the efficacy and safety of GB001 when added to standard-of care (SOC) asthma…NCT03683576·Birmingham, Alabama and 116 others

CompletedTreatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.This protocol is comprised of two separate, but linked, clinical trials for treating preschool-aged children with recurrent severe episodes of wheezing.NCT01272635·Tucson, Arizona and 15 others

CompletedEfficacy and Safety of BI 655066/ABBV-066 (Risankizumab) in Patients With Severe Persistent AsthmaThe objectives of this trial are primarily to evaluate the efficacy and safety of BI 655066/ABBV-066 (risankizumab) as compared to placebo over a 24-week treatment period in…NCT02443298·Costa Mesa, California and 64 others

CompletedEValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 PatientsPrimary Objective -To evaluate the efficacy of dupilumab compared to omalizumab in reducing the polyp size and improving sense of smell Secondary Objectives * To evaluate the…NCT04998604·Los Angeles, California and 86 others

CompletedStudy of Daclizumab in Patients With Chronic, Persistent AsthmaThe purpose of the study is to evaluate an investigational medication to treat chronic persistent asthma.NCT00028288·Long Beach, California and 17 others

CompletedPrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network StudyThe primary objective of this study is to evaluate several interventions given to participants with severe asthma.NCT04129931·Scottsdale, Arizona and 28 others

Page 1 of 8Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia